Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.

A new study aimed to examine associations between dietary patterns and survival among Black women diagnosed with epithelial ...

A combination of two drugs that can block the growth of cancer cells has shown promising results in women with a form of ...

Women with a type of ovarian cancer that is very difficult to treat have shown remarkable results on a clinical trial testing ...

The completion of a new drug application for the combination of avutometinib and defactinib in KRAS-mutant ovarian cancer is ...

There are six hidden warnings of "silent killer" ovarian cancer every woman needs to know - whatever their age. Around 7,000 women in the UK are diagnosed with ovarian cancer every year ...

Tumours shrank or stopped growing in almost one in three women (31 per cent) with low-grade serous ovarian cancer, which does ...

Advertising “This is the first time that a head-to-head study of all available ovarian cancer tests have been done in the same population. Here we studied their use with symptomatic ...

Whether $5 or $50, every contribution counts. The world’s first vaccine for ovarian cancer – being developed in the UK – could wipe out the deadly disease, researchers say. Scientists at the ...

Ovarian cancer affects the ovaries – two small oval-shaped organs that are part of the female reproductive system. Cancer can occur in the ovaries when abnormal cells begin to grow and divide in ...

Your support makes all the difference. Excitement is building as the world’s first vaccine for ovarian cancer is being developed by researchers at the University of Oxford. The hope is that the ...

Scientists have been awarded funding to create the world’s first ovarian cancer vaccine. OvarianVax, is a vaccine that will teach the immune system to recognise and attack the earliest stages of ...